3
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T11466 | GSK-2793660 | Others | |
GSK-2793660 is an orally active and irreversible inhibitor of Cathepsin C (CTSC). GSK-2793660 is a bioactive dipeptide that can be used for the research of bronchiectasis [1] [2]. | |||
T27468 | GSK2793660 HCl | GSK-2793660,GSK2793660,GSK 2793660 | |
GSK2793660 is a irreversible covalent α,β-unsaturated amide based DPP1 inhibitor. | |||
T70381 | GSK2793660 free base | ||
GSK-2793660 is a cathepsin C inhibitor that may be useful in the treatment of cystic fibrosis, noncystic fibrosis bronchiectasis, ANCA-associated vasculitis and bronchiectasis. |